accountdevelopment program for VEGF Trap-Eye TARRYTOWN, N.Y. and BERLIN, April 8, 2011 /PRNewswire via COMTEX/ -- Regeneron Pharmaceuticals, Inc. /quotes/comstock/15*!regn/quotes/nls/regn (REGN 43.60, -1.37, -3.05%) and Bayer HealthCare today announced that...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account